Health Sciences Acquisitions Corporation

Status: Deal Closed
U=S+W W=S/2@11.5
IPO Proceeds, $M $115.00M
IPO Date May 10, 2019
CEO Roderick Wong, MD
Left Lead Chardan
IPO Cash in Trust 100.0%
SPAC Tenor 24 months
IPO Sector Healthcare

Biopharma & medical technology in North America or Europe

IPO Geography North America/Europe
Target Company Immunovant
Deal Announced Oct 2, 2019
Deal Size, $M $555.75M
Deal Sector Healthcare
Deal Geography US/Canada
SEC Filings www.sec.gov
Approval Vote Dec 16, 2019
Amendment Vote TBD
Closing Date Dec 18, 2019
Formerly HSAC IMVT IMVTW

Sign up for Free Trial

No credit card required

Sign in for more on Health Sciences Acquisitions Corporation:

  • Structure and cap table
  • 9 directors & officers
  • 29 filings and events
  • 2 underwriters
  • 2 deal advisors
  • 2 legal advisors
Structure

Sign in to view structure, cap table, and calendar of events.

Team
Name Age Title
Roderick Wong, MD 41 President, CEO & Chairman
Naveen Yalamanchi, MD 42 EVP, CFO & Director
Alice Lee, JD 48 VP of Operations, Secretary & Treasurer
Stephanie A. Sirota 44 VP of Corporate Strategy & Corporate Communications
Mark Schoenebaum, MD 46 Director
Sukumar Nagendran, MD 52 Director
Pedro Granadillo 71 Director
George Migausky 64 Director
Gotham Makker, MD 45 Director

Sign in to view team biographies and more sponsor and affiliate data.

Advisors
Underwriters
Chardan Joint BR 7,000,000 units
UBS Joint BR 3,000,000
10,000,000 units
Up-Front UW fee 2.00 %
Deferred UW fee 3.50 %

Sign in to view more advisor data.

Deal

Sign in to view merger details and deal financials.

Filings

Sign in to view 29 filings.

Shareholders

Sign in to view shareholders 13F filing data.